Contents:
Radical removal of all dead and infected tissue is necessary. The chronic infection requires surgery as well. This state-of-the-art, minimally invasive treatment approach allows surgeons to access the tumor through the natural corridor of the nose, without making an open incision. Surgeons then remove the infected tissue through the nose and nasal cavities. People with invasive fungal sinusitis need to remain under long-term observation by a doctor, as recurrence is common.
Browse UPMC doctors and medical professionals to find the care that's right for you. Customize your search by specialty, zip code, last name, and more. Browse addresses and contact information for our network of hospitals, specialty care practices, and community health locations. Learn more about how to pay your UPMC bill. Find resources including payment methods and contact information for assistance.
Advance your career with UPMC. Discover our latest job listings and learn about our values and career pathways. Overview What is Invasive Fungal Sinusitis? There are two primary types of invasive fungal sinus infections, acute and chronic.
Benefits of EEA include: No incisions to heal No disfigurement Faster recovery time. Symptoms of invasive fungal sinusitis People with invasive fungal sinusitis usually are very ill, and may have some of the following symptoms: Fever Facial pain or numbness Facial swelling Cough Nasal discharge Headache Mental status changes Dark ulcers within the nasal canal or on the roof of the mouth Visual disturbances Symptoms of chronic invasive fungal sinusitis Those with chronic invasive fungal sinusitis usually have symptoms of a long-standing sinus infection, including: Congestion Drainage Pressure in the forehead, nose, and behind the eyes Orbital apex syndrome is also characteristic of the chronic sinus infection.
Treatment Invasive Fungal Sinusitis Treatments Acute invasive fungal sinusitis is a medical emergency, and surgery to remove the infected tissue should be performed immediately once the diagnosis is made. This symptom complex was previously called at least four names, including mucormycosis depending on the organism. When this syndrome has been caused by saprophytic fungi of the order Mucorales , including rhizopus, rhizomucor, absidia, mucor, cunninghamella, mortierella, saksenaea, and apophysomyces , it has been called zygomycosis.
An identical syndrome has been described with Aspergillus , Fusarium , and Pseudallescheria boydii infections and has been called fulminant invasive sinusitis. Histopathological studies show hyphal invasion of blood vessels, including the carotid arteries and cavernous sinuses, vasculitis with thrombosis, hemorrhage and tissue infarction. Treatment includes simultaneous surgical removal of devitalized tissue down to healthy tissue planes, and antifungal therapy, previously given at conventional doses Surgery should be performed for histopathological evaluation and to debride the devitalized tissue supporting fungal growth.
When histopathological studies confirm tissue invasion, treatment with high dose antifungal therapy should be initiated immediately, without waiting for the results of fungal cultures, and for intervals determined by the clinical response. Close collaboration between medical and surgical specialists is essential in the care of these patients.
Obviously, treatment of underlying immunodeficiency, or reconstitution of the iatrogenic immunodeficiency, is desirable but often difficult. The condition may recur after apparently successful treatment when immunosuppression is ongoing and requires chronic suppressive therapy. Although sporadic reports of patients with a syndrome resembling chronic invasive fungal sinusitis have been published, it has only recently been recognized as a specific form of fungal sinusitis 3 , 4. Chronic invasive fungal sinusitis results from a slowly progressive fungal infection that elicits limited inflammation, usually in diabetic patients.
Am J Rhinol Allergy. May-Jun;27 Suppl 1:S doi: /ajra. Chapter 8: Invasive fungal rhinosinusitis. Duggal P(1), Wise SK. Acute Invasive Fungal Rhinosinusitis. Acute invasive FRS is a devastating form of sinonasal fungal disease.
As opposed to the neutrophil-rich, highly necrotic, and angiotrophic process seen in acute invasive fungal sinusitis, there is a low-grade mixed cellular infiltrate in affected tissues Thick nasal polyposis and thick purulent mucus, like that seen grossly in allergic fungal sinusitis and mycetoma, are also common. When the infection expands out of the ethmoid sinuses medically into the orbit, orbital apex syndrome has been a common clinical presentation 23 , 24 Fig. This condition results from erosion of the fungal mass into the orbital apex, causing decreasing vision and abnormalities of ocular mobility.
Proptosis may also occur. Chronic invasive fungal sinusitis may be advanced by the time of diagnosis, with posterior erosion out of the ethmoid sinus, resulting in cerebrovascular accidents from cavernous venous thrombosis and death. Treatment is the same as for acute invasive disease, with surgery and antifungal therapy. The role of newer oral antifungal agents in invasive fungal sinusitis is unclear but promising In infections with organisms resistant to amphotericin B, such as Pseudallescheria boydii , azole therapy has been reported to be lifesaving.
Axial computed tomographic scan in a patient with invasive fungal sinusitis showing bone erosion of the left lamina papyracea arrow with soft tissue thickening of the lateral nasal and medial canthal areas. There is also extensive unilateral nasal cavity soft tissue thickening on the left side. An increasing array of antimicrobial agents is available to treat invasive fungal sinusitis.
Examples include the azoles itraconazole , traizoles voriconazole and echinocandins caspofungin in addition to the gold-standard polyene, amphotericin B deoxycholate and its lipid-based cousins. In the case of aspergillosis, no controlled studies are available on antimicrobial treatment of invasive fungal sinusitis. Amphotericin-B treatment requires 1—1.
Therefore, lipid formulations became the standard of care for polyene therapy in invasive aspergillosis Abelcet or AmBisome. Even then, Aspergillus species such as A. Therefore, voriconazole has become the treatment of choice for invasive aspergillus sinusitis when the diagnosis is established as such Patients with acute invasive aspergillosis who were not ventilator dependent showed a greater percentage of complete or partial response, lower mortality rate and a lower incidence of side effects with this regimen.
Since this drug has little activity against zygomycetes, it should not be used unless the diagnosis of aspergillosis has been made. Itraconazole is one of several second line drugs for treatments for aspergillosis since voriconazole has greater activity with fewer side effects.
Caspofungin is approved for treatment of invasive aspergillosis in patients who cannot tolerate or are refractory to voriconazole. After an initial dose of 70mg i. With an ever increasing number of effective therapies for cancer and autoimmune disease that also cause suppression of cell mediated immunity, fungal disease and fungal sinusitis will be a growing problem. Now that diagnostic criteria are available, multicenter trials comparing diagnostic and therapeutic approaches are greatly needed. The author thanks Leigh Wright, BA for her assistance with the preparation and Stanley Chapman for review of this manuscript.
The author has received no source of funding for this paper. The author reports no conflicts of interest. The author alone is responsible for the content and writing of the paper. Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide.
Sign In or Create an Account. Close mobile search navigation Article navigation. Syndromes of invasive fungal sinusitis Richard D. Abstract Invasive fungal sinusitis should be suspected in immunocompromised or diabetic patients who present with acute sinusitis, inflammation of nasal septal mucosa, unexplained fever or cough, or the orbital apex syndrome. View large Download slide. Mucosal thickening or air fluid levels compatible with sinusitis on radiologic imaging.
Histopathologic evidence of hyphal forms within sinus mucosa, submucosa, blood vessels, or bone.
To diagnose granulomatous invasive fungal sinusitis, histopathologic evidence of hyphal forms within sinus mucosa, submucosa, blood vessel or bone in association with granuloma containing giant cells is required. Concomitant stains for mycobacteria must be negative.
Fever, cough, crusting of nasal mucosa, epistaxis, headache, mental status changes. Radical debridement to histopathologically normal tissue, antifungal antibiotic treatment of underlying conditions. Fair when limited to sinus; poor with intracranial involvement. A new classification and diagnostic criteria for invasive fungal sinusitis. General principles of management of fungal infections of the head and neck. Diagnosis of invasive aspergillosis using a galactomannan array: Beta-D-glucon as a diagnostic adjunct for invasive fungal infections: Further observations on the primary paranasal Aspergillus granuloma in the Sudan: Postoperative responses of paranasal Aspergillus granuloma to itraconazole.
Acute invasive rhinocerebral zygomycosis in an otherwise healthy patient: Invasive Aspergillus rhinosinusitis in patients with acute leukemia.
Fungal sinusitis in patients with AIDS: Aspergillus sinusitis in patients with AIDS: Invasive Aspergillus sinusitis in pediatric bone marrow transplant patients: Nasal obstruction and bone erosion caused by Drechslera hawaiiensis. Voriconazole versus amphotercin B for primary therapy of invasive aspergillosis. Efficiency and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Email alerts New issue alert. Receive exclusive offers and updates from Oxford Academic. More on this topic Schizophyllum commune: Allergic fungal rhino sinusitis with granulomas: Controversies surrounding the categorization of fungal sinusitis.
Related articles in Web of Science Google Scholar. Citing articles via Web of Science Latest Most Read Most Cited Types of yeasts that cause vulvovaginal candidiasis in chronic users of corticosteroids. Potential clinical utility of ERC-2 yeast phase lysate antigen for antibody detection in dogs with blastomycosis.
A remaining challenge in fungal taxonomy?